File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Secretoneurin induces endothelium-dependent relaxation of the porcine coronary artery
Title | Secretoneurin induces endothelium-dependent relaxation of the porcine coronary artery |
---|---|
Authors | |
Keywords | Pharmacy and pharmacology environmental studies Toxicology and environmental safety |
Issue Date | 2010 |
Publisher | Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/PTO |
Citation | The 16th World Congress on Basic and Clinical Pharmacology (WorldPharma2010), Copenhagen, Denmark, 17-23 July 2010. In Basic & Clinical Pharmacology & Toxicology, 2010, v. 107 suppl. 1, p. 222 How to Cite? |
Abstract | Secretoneurin is a part of the peptide encoded by the Secretogranin II gene. Secretoneurin enhances the adhesion and transendothelial migration properties of monocytes. In addition, in regenerated endothelium, the expression of the Secretogranin II gene is up-regulated. The objective of the present study was to examine the effects of Secretoneurin on the vascular reactivity. Isometric tension of rings with or without endothelium from porcine coronary arteries was measured in conventional organ chambers. Secretoneurin did not induce contraction, but in preparations contracted by the TP-receptor agonist U46619 it caused relaxation. This relaxation was endothelium-dependent and reduced by the nitric oxide synthase inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME). It was abolished by combined incubation with L-NAME and the cyclooxygenase inhibitor indomethacin. By contrast the relaxation to secretoneurin was not affected by TRAM 34 and UCL 1684. These results suggest that secretoneurin induces relaxation by activation of both endothelial nitric oxide synthase and cyclooxygenase, with the nitric oxide pathway playing a more dominant role. |
Description | Focused Conference Group: P15 – Endotheliumin Health and Disease. Paper no. 2224 |
Persistent Identifier | http://hdl.handle.net/10722/126889 |
ISSN | 2023 Impact Factor: 2.7 2023 SCImago Journal Rankings: 0.744 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, CKY | en_HK |
dc.contributor.author | Mak, JCW | en_HK |
dc.contributor.author | Vanhoutte, PM | en_HK |
dc.date.accessioned | 2010-10-31T12:54:27Z | - |
dc.date.available | 2010-10-31T12:54:27Z | - |
dc.date.issued | 2010 | en_HK |
dc.identifier.citation | The 16th World Congress on Basic and Clinical Pharmacology (WorldPharma2010), Copenhagen, Denmark, 17-23 July 2010. In Basic & Clinical Pharmacology & Toxicology, 2010, v. 107 suppl. 1, p. 222 | en_HK |
dc.identifier.issn | 1742-7835 | - |
dc.identifier.uri | http://hdl.handle.net/10722/126889 | - |
dc.description | Focused Conference Group: P15 – Endotheliumin Health and Disease. Paper no. 2224 | - |
dc.description.abstract | Secretoneurin is a part of the peptide encoded by the Secretogranin II gene. Secretoneurin enhances the adhesion and transendothelial migration properties of monocytes. In addition, in regenerated endothelium, the expression of the Secretogranin II gene is up-regulated. The objective of the present study was to examine the effects of Secretoneurin on the vascular reactivity. Isometric tension of rings with or without endothelium from porcine coronary arteries was measured in conventional organ chambers. Secretoneurin did not induce contraction, but in preparations contracted by the TP-receptor agonist U46619 it caused relaxation. This relaxation was endothelium-dependent and reduced by the nitric oxide synthase inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME). It was abolished by combined incubation with L-NAME and the cyclooxygenase inhibitor indomethacin. By contrast the relaxation to secretoneurin was not affected by TRAM 34 and UCL 1684. These results suggest that secretoneurin induces relaxation by activation of both endothelial nitric oxide synthase and cyclooxygenase, with the nitric oxide pathway playing a more dominant role. | - |
dc.language | eng | en_HK |
dc.publisher | Blackwell Publishing Ltd. The Journal's web site is located at http://www.blackwellpublishing.com/journals/PTO | - |
dc.relation.ispartof | Basic & Clinical Pharmacology & Toxicology | en_HK |
dc.rights | The definitive version is available at www.blackwell-synergy.com | - |
dc.subject | Pharmacy and pharmacology environmental studies | - |
dc.subject | Toxicology and environmental safety | - |
dc.title | Secretoneurin induces endothelium-dependent relaxation of the porcine coronary artery | en_HK |
dc.type | Conference_Paper | en_HK |
dc.identifier.openurl | http://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1742-7835&volume=107, suppl. 1&spage=222&epage=&date=2010&atitle=Secretoneurin+induces+endothelium-dependent+relaxation+of+the+porcine+coronary+artery | - |
dc.identifier.email | Chan, CKY: chancalvink@gmail.com | en_HK |
dc.identifier.email | Mak, JCW: judymak@HKUCC.hku.hk | en_HK |
dc.identifier.email | Vanhoutte, PM: vanhoutt@hku.hk | en_HK |
dc.identifier.hkuros | 175327 | en_HK |
dc.identifier.volume | 107 | en_HK |
dc.identifier.issue | suppl. 1 | - |
dc.identifier.spage | 222 | en_HK |
dc.identifier.epage | 222 | - |
dc.description.other | The 16th World Congress on Basic and Clinical Pharmacology (WorldPharma2010), Copenhagen, Denmark, 17-23 July 2010. In Basic & Clinical Pharmacology & Toxicology, 2010, v. 107, suppl. 1, p. 222 | - |
dc.identifier.issnl | 1742-7835 | - |